实现“以生物造万物” 北京昌平合成生物企业同比增长近七成

Core Insights - The synthetic biology manufacturing industry in Changping District, Beijing, is experiencing significant growth, with the number of enterprises increasing by nearly 70% compared to the same period in 2025 [1][2] - Microbial "workers" are efficiently producing various bio-manufactured products such as allulose and feed proteins, showcasing the industrial capabilities of synthetic biology [1][2] Industry Overview - As of now, there are 146 synthetic biology manufacturing companies established in Changping, indicating a robust expansion in the sector [2] - The industry is entering a new phase of cluster development, with a focus on various subfields including bio-based materials, collagen, biological breeding, and gas fermentation [2] Company Developments - Micro Yuan Synthetic Biology Technology (Beijing) Co., Ltd. has successfully commercialized products like mannitol, allulose, and xylitol, and is advancing multiple product lines in human nutrition, animal nutrition, daily chemical raw materials, and pharmaceutical excipients [1] - The company has grown from a few employees to a team of hundreds, with over 60% being research and development personnel, highlighting its commitment to innovation [1] Future Goals - Changping District aims to establish 10 landmark synthetic biology manufacturing projects by 2026 and achieve an industry revenue exceeding 10 billion yuan [2] - The district plans to transition from regional leadership to national influence, aspiring to become a significant source of innovation and a leading area in synthetic biology manufacturing [2]